256 related articles for article (PubMed ID: 19001140)
1. Tpl2 kinase regulates T cell interferon-gamma production and host resistance to Toxoplasma gondii.
Watford WT; Hissong BD; Durant LR; Yamane H; Muul LM; Kanno Y; Tato CM; Ramos HL; Berger AE; Mielke L; Pesu M; Solomon B; Frucht DM; Paul WE; Sher A; Jankovic D; Tsichlis PN; O'Shea JJ
J Exp Med; 2008 Nov; 205(12):2803-12. PubMed ID: 19001140
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of TPL2/MAP3K8 blocks human cytotoxic T lymphocyte effector functions.
Chowdhury FZ; Estrada LD; Murray S; Forman J; Farrar JD
PLoS One; 2014; 9(3):e92187. PubMed ID: 24642963
[TBL] [Abstract][Full Text] [Related]
3. Tpl2 Promotes Innate Cell Recruitment and Effector T Cell Differentiation To Limit Citrobacter rodentium Burden and Dissemination.
Acuff NV; Li X; Latha K; Nagy T; Watford WT
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28760932
[TBL] [Abstract][Full Text] [Related]
4. Tumor Progression Locus 2 Promotes Induction of IFNλ, Interferon Stimulated Genes and Antigen-Specific CD8+ T Cell Responses and Protects against Influenza Virus.
Kuriakose T; Tripp RA; Watford WT
PLoS Pathog; 2015 Aug; 11(8):e1005038. PubMed ID: 26241898
[TBL] [Abstract][Full Text] [Related]
5. Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii.
Cai G; Radzanowski T; Villegas EN; Kastelein R; Hunter CA
J Immunol; 2000 Sep; 165(5):2619-27. PubMed ID: 10946290
[TBL] [Abstract][Full Text] [Related]
6. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
[TBL] [Abstract][Full Text] [Related]
7. Tumor progression locus 2 differentially regulates IFNγ and IL-17 production by effector CD4+ T cells in a T cell transfer model of colitis.
Acuff NV; Li X; Kirkland R; Nagy T; Watford WT
PLoS One; 2015; 10(3):e0119885. PubMed ID: 25781948
[TBL] [Abstract][Full Text] [Related]
8. Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 beta production.
Mielke LA; Elkins KL; Wei L; Starr R; Tsichlis PN; O'Shea JJ; Watford WT
J Immunol; 2009 Dec; 183(12):7984-93. PubMed ID: 19933865
[TBL] [Abstract][Full Text] [Related]
9. TLR11-independent inflammasome activation is critical for CD4+ T cell-derived IFN-γ production and host resistance to Toxoplasma gondii.
López-Yglesias AH; Camanzo E; Martin AT; Araujo AM; Yarovinsky F
PLoS Pathog; 2019 Jun; 15(6):e1007872. PubMed ID: 31194844
[TBL] [Abstract][Full Text] [Related]
10. A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation.
Sugimoto K; Ohata M; Miyoshi J; Ishizaki H; Tsuboi N; Masuda A; Yoshikai Y; Takamoto M; Sugane K; Matsuo S; Shimada Y; Matsuguchi T
J Clin Invest; 2004 Sep; 114(6):857-66. PubMed ID: 15372110
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses.
Zhu J; Jankovic D; Oler AJ; Wei G; Sharma S; Hu G; Guo L; Yagi R; Yamane H; Punkosdy G; Feigenbaum L; Zhao K; Paul WE
Immunity; 2012 Oct; 37(4):660-73. PubMed ID: 23041064
[TBL] [Abstract][Full Text] [Related]
12. Ablation of tumor progression locus 2 promotes a type 2 Th cell response in Ovalbumin-immunized mice.
Watford WT; Wang CC; Tsatsanis C; Mielke LA; Eliopoulos AG; Daskalakis C; Charles N; Odom S; Rivera J; O'Shea J; Tsichlis PN
J Immunol; 2010 Jan; 184(1):105-13. PubMed ID: 19955521
[TBL] [Abstract][Full Text] [Related]
13. TPL2 Kinase Is a Crucial Signaling Factor and Mediator of NKT Effector Cytokine Expression in Immune-Mediated Liver Injury.
Vyrla D; Nikolaidis G; Oakley F; Perugorria MJ; Tsichlis PN; Mann DA; Eliopoulos AG
J Immunol; 2016 May; 196(10):4298-310. PubMed ID: 27053764
[TBL] [Abstract][Full Text] [Related]
14. T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii.
Shaw MH; Reimer T; Sánchez-Valdepeñas C; Warner N; Kim YG; Fresno M; Nuñez G
Nat Immunol; 2009 Dec; 10(12):1267-74. PubMed ID: 19881508
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cell intrinsic toll-like receptor MyD88 signaling contributes to IL-12-dependent IFN-γ production by mice during infection with Toxoplasma gondii.
Ge Y; Chen J; Qiu X; Zhang J; Cui L; Qi Y; Liu X; Qiu J; Shi Z; Lun Z; Shen J; Wang Y
Int J Parasitol; 2014 Jun; 44(7):475-84. PubMed ID: 24727091
[TBL] [Abstract][Full Text] [Related]
16. T cell-derived interferon-γ is required for host defense to Toxoplasma gondii.
Nishiyama S; Pradipta A; Ma JS; Sasai M; Yamamoto M
Parasitol Int; 2020 Apr; 75():102049. PubMed ID: 31901434
[TBL] [Abstract][Full Text] [Related]
17. STAT1 plays a critical role in the regulation of antimicrobial effector mechanisms, but not in the development of Th1-type responses during toxoplasmosis.
Lieberman LA; Banica M; Reiner SL; Hunter CA
J Immunol; 2004 Jan; 172(1):457-63. PubMed ID: 14688355
[TBL] [Abstract][Full Text] [Related]
18. IL-12 Mediates T-bet-Expressing Myeloid Cell-Dependent Host Resistance against Toxoplasma gondii.
Schanz ML; Bitters AM; Zadeii KE; Joulani D; Chamberlain AK; López-Yglesias AH
Immunohorizons; 2024 Apr; 8(4):355-362. PubMed ID: 38687282
[TBL] [Abstract][Full Text] [Related]
19. IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii Infection.
Wilson DC; Matthews S; Yap GS
J Immunol; 2008 May; 180(9):5935-45. PubMed ID: 18424713
[TBL] [Abstract][Full Text] [Related]
20. Host resistance and immune deviation in pigeon cytochrome c T-cell receptor transgenic mice infected with Toxoplasma gondii.
Collazo CM; Miller C; Yap G; Hieny S; Caspar P; Schwartz RH; Sher A
Infect Immun; 2000 May; 68(5):2713-9. PubMed ID: 10768964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
